Royal Sense [ROYAL] vs Entero Healthcare [ENTERO] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Royal Sense Ltd. wins in 11 metrics, Entero Healthcare Solutions wins in 7 metrics, with 0 ties. Royal Sense Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Royal Sense Ltd. | Entero Healthcare Solutions | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 14.61 | 48.93 | Royal Sense Ltd. |
| Price-to-Book Ratio | 2.60 | 3.11 | Royal Sense Ltd. |
| Debt-to-Equity Ratio | 19.41 | 24.63 | Royal Sense Ltd. |
| PEG Ratio | N/A | 5.72 | N/A |
| EV/EBITDA | 8.50 | 28.71 | Royal Sense Ltd. |
| Profit Margin (TTM) | 9.63% | 1.87% | Royal Sense Ltd. |
| Operating Margin (TTM) | 13.28% | 3.40% | Royal Sense Ltd. |
| EBITDA Margin (TTM) | 13.28% | 3.40% | Royal Sense Ltd. |
| Return on Equity | 28.62% | 5.36% | Royal Sense Ltd. |
| Return on Assets (TTM) | 18.97% | 3.51% | Royal Sense Ltd. |
| Free Cash Flow (TTM) | $-4.08M | $-881.80M | Royal Sense Ltd. |
| 1-Year Return | -47.91% | -0.41% | Entero Healthcare Solutions |
| Price-to-Sales Ratio (TTM) | 1.11 | 0.91 | Entero Healthcare Solutions |
| Enterprise Value | $977.38M | $58.10B | Entero Healthcare Solutions |
| EV/Revenue Ratio | 1.18 | 0.97 | Entero Healthcare Solutions |
| Gross Profit Margin (TTM) | 15.60% | 10.11% | Royal Sense Ltd. |
| Revenue per Share (TTM) | $161 | $1,383 | Entero Healthcare Solutions |
| Earnings per Share (Diluted) | $11.83 | $25.83 | Entero Healthcare Solutions |
| Beta (Stock Volatility) | 0.59 | -0.79 | Entero Healthcare Solutions |
Royal Sense Ltd. vs Entero Healthcare Solutions Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Royal Sense Ltd. | -2.45% | -7.48% | -22.77% | -28.21% | -38.47% | -33.31% |
| Entero Healthcare Solutions | -2.17% | -10.21% | -6.57% | 12.44% | 9.42% | 2.02% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Royal Sense Ltd. | -47.91% | 14.02% | 14.02% | 14.02% | 14.02% | 14.02% |
| Entero Healthcare Solutions | -0.41% | 4.02% | 4.02% | 4.02% | 4.02% | 4.02% |
Performance & Financial Health Analysis: Royal Sense Ltd. vs Entero Healthcare Solutions
| Metric | ROYAL | ENTERO |
|---|---|---|
| Market Information | ||
| Market Cap | ₹924.51M | ₹54.69B |
| Market Cap Category | Small cap | Mid cap |
| 10 Day Avg. Volume | 14,200 | 76,067 |
| 90 Day Avg. Volume | 8,000 | 89,093 |
| Last Close | ₹117.65 | ₹1,127.40 |
| 52 Week Range | ₹115.00 - ₹309.75 | ₹944.00 - ₹1,390.00 |
| % from 52W High | -62.02% | -18.89% |
| All-Time High | ₹316.05 (Dec 30, 2024) | ₹1,584.25 (Nov 04, 2024) |
| % from All-Time High | -62.77% | -28.84% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 2.93% | 0.26% |
| Quarterly Earnings Growth | 1.11% | 0.09% |
| Financial Health | ||
| Profit Margin (TTM) | 0.10% | 0.02% |
| Operating Margin (TTM) | 0.13% | 0.03% |
| Return on Equity (TTM) | 0.29% | 0.05% |
| Debt to Equity (MRQ) | 19.41 | 24.63 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹66.58 | ₹405.79 |
| Cash per Share (MRQ) | ₹1.87 | ₹37.37 |
| Operating Cash Flow (TTM) | ₹-70,281,000 | ₹-1,784,990,000 |
| Levered Free Cash Flow (TTM) | ₹-150,242,752 | ₹948.20M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Royal Sense Ltd. vs Entero Healthcare Solutions
| Metric | ROYAL (Apr 22, 2026) | ENTERO (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 14.61 | 48.93 |
| Forward P/E | N/A | 28.42 |
| PEG Ratio | N/A | 5.72 |
| Price to Sales (TTM) | 1.11 | 0.91 |
| Price to Book (MRQ) | 2.60 | 3.11 |
| Market Capitalization | ||
| Market Capitalization | ₹924.51M | ₹54.69B |
| Enterprise Value | ₹977.38M | ₹58.10B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.18 | 0.97 |
| Enterprise to EBITDA | 8.50 | 28.71 |
| Risk & Other Metrics | ||
| Beta | 0.59 | -0.79 |
| Book Value per Share (MRQ) | ₹66.58 | ₹405.79 |
Financial Statements Comparison: Royal Sense Ltd. vs Entero Healthcare Solutions
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ROYAL (2025) | ENTERO (2025) |
|---|---|---|
| Revenue/Sales | 617.34M | 50.65B |
| Cost of Goods Sold | 495.71M | 46.09B |
| COGS % of Revenue | 80.3% | 91.0% |
| Gross Profit | 121.63M | 4.56B |
| Gross Margin | 19.7% | 9.0% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 88.67M | 1.42B |
| Operating Margin | 14.4% | 2.8% |
| EBITDA | 88.97M | 2.07B |
| EBITDA Margin | 14.4% | 4.1% |
| Pre-Tax Income | 87.35M | 1.39B |
| Pre-Tax Income % of Revenue | 14.1% | 2.7% |
| Income Tax | 24.03M | 313.05M |
| Income Tax % of Revenue | 3.9% | 0.6% |
| Net Income (Profit) | 63.31M | 1.07B |
| Profit Margin | 10.3% | 2.1% |
Balance Sheet & Liquidity Metrics
| Metric | ROYAL (2025) | ENTERO (2025) |
|---|---|---|
| Cash & Equivalents | 112.47M | 2.29B |
| Total Current Assets | 333.53M | 20.76B |
| Total Current Assets % of Revenue | 54.0% | 41.0% |
| Total Current Liabilities | 76.34M | 8.45B |
| Total Current Liabilities % of Revenue | 12.4% | 16.7% |
| Long-Term Debt | 1.05M | 670.18M |
| Long-Term Debt % of Revenue | 0.2% | 1.3% |
| Total Shareholders Equity | 277.37M | 17.70B |
| Retained Earnings | 79.20M | 638.28M |
| Retained Earnings % of Revenue | 12.8% | 1.3% |
| Property, Plant & Equipment | 0 | 1.64B |
Cash Flow Statement Comparison
| Metric | ROYAL (2025) | ENTERO (2025) |
|---|---|---|
| Operating Cash Flow | 5.21M | -1.78B |
| Operating Cash Flow % of Revenue | 0.8% | -3.5% |
| Capital Expenditures | -16.16M | -103.73M |
| Free Cash Flow | -4.08M | -881.80M |
| FCF Margin | -0.7% | -1.7% |
| Debt Repayment | -1.16M | -458.22M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ROYAL | ENTERO |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 4.90M | 43.51M |
| Float Shares | 1.60M | 14.37M |
| % Held by Insiders | 68.64% | 65.97% |
| % Held by Institutions | 0.00% | 12.55% |
| % Held by Public | 31.36% | 21.48% |
Dividend Analysis & Yield Comparison: Royal Sense Ltd. vs Entero Healthcare Solutions
| Metric | ROYAL | ENTERO |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |